 |
|
|
| |
Weight Gain After ARV Initiation Correlates with Increased
Inflammatory Biomarkers
|
| |
| |
Reported by jules Levin
22nd International AIDS Conference, Amsterdam, Netherlands, July 23-27, 2018
E. Laidlaw1, A. Gouel-Cheron1, S. Kuriakose2, A. Pau1, A. Rupert2, M. Nason1, V. Sheikh1, J. Mican1, M. Manion1, I. Sereti1
1NIAID/National Institutes of Health (NIH), Bethesda, MD, USA; 2Leidos Biomedical Research, Inc., Frederick, MD, USA
References
1. Lake, JE. "The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection." Current HIV/AIDS Reports. 18 October 2017.
2. Justice AC, Erlandson KM, Miotti PG, et al. Can Biomarkers Advance HIV Research and Care in the ART Era? Journal of Infectious Disease. 2017 November 20. Jix586.
3. Bhagwat P, Ofotokun I, McComsey GA et al. "Predictors of Severe Weight/Body Mass Index Gain Following Antiretroviral Initiation." CROI. UCLA, ACTG. Seattle, Washington. 13-16 February 2017. Poster Presentation: #695.
4. Mascolini M. Bigger Weight Gains with Contemporary PI Regimens than with NNRTIs or INIs. 16th European AIDS Conference. October 2017.
5. Norwood J, Turner M, Bofill C, et al. Weight Gain in Persons with HIV Switched from Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens. Journal of Acquired Immune Deficiency Syndrome. 2017 December 15;
76(5):527-531.
6. Taramasso L, Ricci E, Menzaghi B, et al. Weight Gain: A Possible Side Effect of All Antiretrovirals. Open Forum Infect Dis. 2017 Nov 3;4(4):ofx239.
7. Conley LJ, Bush TJ, Rupert AW, Sereti I, et al. "Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy. AIDS. 23 October 2015. 29 (16): 2201-7.
|
| |
|
|
|
|
|
